The impact of statin-ezetimibe combination therapy versus statin monotherapy on coronary plaque regression in patients with acute coronary syndrome: a meta-analysis

The impact of statin-ezetimibe combination therapy versus statin monotherapy on coronary plaque regression in patients with acute coronary syndrome: a meta-analysis

Objective: To investigate the effects of statin monotherapy and statin-ezetimibe combination therapy on coronary plaque regression in acute coronary syndrome patients. Methods: The systematic review was conducted from July to September 2022 and comprised search on PubMed, ScienceDirect and Cochrane...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yusra Pintaningrum, Ketut Angga Aditya Putra Pramana
Format:	Article
Language:	English
Published:	Pakistan Medical Association 2024-07-01
Series:	Journal of the Pakistan Medical Association
Online Access:	https://jpma.org.pk/index.php/public_html/article/view/21452
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The clinical effectiveness and safety of low/moderate-intensity statins & ezetimibe combination therapy vs. high-intensity statin monotherapy: a systematic review and meta-analysis
by: Pishoy Sydhom, et al.
Published: (2024-11-01)

Combination of statin and ezetimibe in the post-infarction period
by: Valentin E. Oleynikov, et al.
Published: (2024-12-01)

Efficacy and safety of statins, ezetimibe, and fibrates monotherapy or combination therapy for hyperlipidemia: a systematic review and network meta-analysis
by: Shujie Zhang, et al.
Published: (2025-06-01)

ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia
by: M. Yu. Zubareva, et al.
Published: (2010-12-01)

Protocol for a systematic review and meta-analysis of the combination of ezetimibe and statins for hyperlipidemia
by: Tianfu Yang, et al.
Published: (2024-01-01)

Protocol for a systematic review and meta-analysis of the combination of ezetimibe and statins for hyperlipidemia.
by: Tianfu Yang, et al.
Published: (2024-01-01)

Evolocumab Added to Statin Is Associated With Intracranial Atherosclerotic Plaque Regression Compared With Statin Alone
by: Xinzhi Hu, et al.
Published: (2025-08-01)

Addition of Bempedoic Acid to Statin–Ezetimibe versus Statin Titration in Patients with High Cardiovascular Risk: A Single-Centre Prospective Study
by: Giuseppe Marazzi, et al.
Published: (2024-09-01)

STATINS IN ACUTE CORONARY SYNDROMES
by: A. L. Alyavi, et al.
Published: (2019-03-01)

Statins in acute coronary syndrome
by: O. M. Drapkina
Published: (2009-10-01)

Lipid profile and safety of rosuvastatin monotherapy versus rosuvastatin plus ezetimibe in high risk coronary artery disease: a systematic review and meta-analysis of randomized controlled trials
by: Arga Setyo Adji, et al.
Published: (2025-06-01)

Multimodal assessment of treatment with proprotein convertase subtilisin/kexin type 9 inhibitors combined with statins for regulating coronary artery plaque regression in patients with chronic/acute coronary syndrome: A meta-analysis
by: Dexiao Yuan, et al.
Published: (2025-08-01)

Ineffective statin monotherapy: alternative therapeutic strategy
by: I. V. Sergienko
Published: (2011-08-01)

Clinical Outcomes of Ezetimibe Plus Statins in Patients With Lower Extremity Artery Disease
by: Yoshihiro Iwasaki, MD, PhD, et al.
Published: (2025-09-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

The influence of antibiotics and statins on inflammation in coronary disease
by: Stojanović Radan M., et al.
Published: (2005-01-01)

Efficacy and safety of inclisiran versus PCSK9 inhibitor versus statin plus ezetimibe therapy in hyperlipidemia: a systematic review and network meta-analysis
by: Shengxuan Zhang, et al.
Published: (2024-11-01)

Various doses of statins and coronary angiogenesis in patients with coronary heart disease
by: I. V. Sergienko, et al.
Published: (2009-10-01)

Triple Non-Statin Therapy with Ezetimibe, Inclisiran, and Bempedoic Acid in Patients with Genetically Confirmed Statin-Induced Rhabdomyolysis: A Dual Case Report
by: Jozef Dodulík, et al.
Published: (2025-05-01)

Effect of different statins and EZETIMIBE/SIMVASTATIN on cardiovascular disease in patients with chronic kidney disease
by: ZHANG Xue-qing, et al.
Published: (2018-01-01)

Switch to Rosuvastatin Plus Ezetimibe From Statin Monotherapy to Achieve Target LDL-Cholesterol Goal: A Multi-Center, Open-Label, Single-Arm Trial
by: Hong-Kyun Park, et al.
Published: (2025-05-01)

Statins: Cardiovascular Risk Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of Hyperacute Use of Statins
by: Enrique C. Morales-Villegas, et al.
Published: (2011-01-01)

Statin therapy and atherosclerosis regression
by: A. V. Susekov
Published: (1970-01-01)

Statin versus no statin after treatment with pipeline embolization device for intracranial aneurysms: a meta-analysis
by: Nathalia Soares Barbosa, et al.
Published: (2025-06-01)

Randomised study of ezetimibe, start doses of original statins, and their combination in patients with coronary heart disease and hyperlipidemia Part 2. Therapy effects on the levels of C-reactive protein and proinflammatory cytokines
by: A. V. Susekov, et al.
Published: (2011-12-01)

COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE
by: S. V. Shalaev, et al.
Published: (2016-01-01)

Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis
by: M. V. Klimushina, et al.
Published: (2016-11-01)

Statin Monotherapy Not Inferior to Aspirin or Combined Aspirin and Statins Reducing the Incidences of Cirrhosis, HCC, and Mortality in MAFLD/MASH Patients: A Population Cohort Study
by: Lee CH, et al.
Published: (2024-12-01)

Coronary computed tomography angiography versus guideline-recommended clinical risk assessment for statin allocation in outpatients with suspected coronary artery disease
by: Jianan Zheng, et al.
Published: (2025-06-01)

PERSONALIZED STATIN THERAPY IN IMPROVING THE TREATMENT OF CORONARY ARTERY DISEASE AND ATHEROSCLEROSIS
by: U. R. Makhmudova, et al.
Published: (2015-06-01)

Long-term statin therapy is associated with severe coronary artery calcification.
by: Kyari Sumayin Ngamdu, et al.
Published: (2023-01-01)

Vulnerable plaques and lipid changes over statin therapy in patients with acute coronary syndrome. Initial data from the Combi-LLT ACS trial
by: G. R. Bikbaeva, et al.
Published: (2025-07-01)

HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE?
by: I. S. Yavelov, et al.
Published: (2017-09-01)

The efficacy and safety of peroperative statin treatment during coronary artery bypass grafting
by: I.V. Shklianka, et al.
Published: (2018-03-01)

NEW OPPORTUNITIES FOR PREVENTIVE THERAPY WITH STATINS DURING CHD PATIENTS’ REHABILITATION, WITH CLINICAL SIGNS OF MODERATE CHF: EFFECTIVENESS OF ROSUVASTATIN AND EZETIMIBE
by: N. I. Tarasov, et al.
Published: (2016-06-01)

Gender difference in hipolipemic and anti-inflammatory effects of statins in diabetics with coronary artery disease
by: Đinđić Boris, et al.
Published: (2009-01-01)

Effects of statins in patients with coronary artery spasm: A nationwide population‐based study
by: Yu‐Ching Lee, et al.
Published: (2024-11-01)

Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry
by: Ying Xian, et al.
Published: (2019-10-01)

Statins and stroke
by: Obradović Dragana, et al.
Published: (2003-01-01)

Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease
by: Rej S, et al.
Published: (2016-11-01)